PL1772456T3 - Nowe krystaliczne postaci polimorficzne klopidogrelu - Google Patents
Nowe krystaliczne postaci polimorficzne klopidogreluInfo
- Publication number
- PL1772456T3 PL1772456T3 PL06124851T PL06124851T PL1772456T3 PL 1772456 T3 PL1772456 T3 PL 1772456T3 PL 06124851 T PL06124851 T PL 06124851T PL 06124851 T PL06124851 T PL 06124851T PL 1772456 T3 PL1772456 T3 PL 1772456T3
- Authority
- PL
- Poland
- Prior art keywords
- forms
- present
- clopidogrel
- novel crystalline
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0321256.0A GB0321256D0 (en) | 2003-09-11 | 2003-09-11 | Novel crystalline compounds |
EP04768414A EP1618113B1 (en) | 2003-09-11 | 2004-09-09 | Novel crystalline polymorphs of clopidogrel |
EP06124851.4A EP1772456B1 (en) | 2003-09-11 | 2004-09-09 | Novel crystalline polymorphs of clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1772456T3 true PL1772456T3 (pl) | 2015-03-31 |
Family
ID=29226875
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06124847T PL1837337T3 (pl) | 2003-09-11 | 2004-09-09 | Nowe krystaliczne formy polimorficzne klopidogrelu |
PL06124851T PL1772456T3 (pl) | 2003-09-11 | 2004-09-09 | Nowe krystaliczne postaci polimorficzne klopidogrelu |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06124847T PL1837337T3 (pl) | 2003-09-11 | 2004-09-09 | Nowe krystaliczne formy polimorficzne klopidogrelu |
Country Status (15)
Country | Link |
---|---|
US (1) | US7897613B2 (pl) |
EP (4) | EP1618113B1 (pl) |
AT (1) | ATE487725T1 (pl) |
AU (1) | AU2004272337B2 (pl) |
CA (3) | CA2536052C (pl) |
CY (1) | CY1115917T1 (pl) |
DE (1) | DE602004029999D1 (pl) |
DK (2) | DK1772456T3 (pl) |
ES (2) | ES2355729T3 (pl) |
GB (1) | GB0321256D0 (pl) |
HU (1) | HUE029256T2 (pl) |
PL (2) | PL1837337T3 (pl) |
PT (1) | PT1772456E (pl) |
SI (1) | SI1772456T1 (pl) |
WO (1) | WO2005026174A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005068471A1 (en) * | 2004-01-13 | 2005-07-28 | Zentiva, A.S. | New crystalline forms of clopidogrel hydrobromide and methods of their preparation |
ZA200608569B (en) * | 2004-04-20 | 2007-12-27 | Sanofi Aventis | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
ZA200608035B (en) | 2004-04-20 | 2008-07-30 | Sanofi Aventis | Clopidogrel salt and polymorphic forms thereof |
WO2006018853A2 (en) | 2004-08-19 | 2006-02-23 | Hetero Drugs Limited | Novel polymorphs of efavirenz |
US20060154957A1 (en) | 2004-09-21 | 2006-07-13 | Nina Finkelstein | Crystalline clopidogrel hydrobromide and processes for preparation thereof |
EP1674468A1 (en) * | 2004-12-21 | 2006-06-28 | Ratiopharm GmbH | Polymorphs of clopidogrel hydrobromide |
CN100417653C (zh) * | 2005-09-08 | 2008-09-10 | 浙江华海药业股份有限公司 | 噻吩并四氢吡啶乙酸及其盐的制备方法 |
WO2007028337A1 (en) * | 2005-09-08 | 2007-03-15 | Zhejiang Huahai Pharmaceutical Co., Ltd. | Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds |
HUE028908T2 (en) * | 2006-04-05 | 2017-01-30 | Opko Health Inc | The hydrochloride salt of 8 - [{1- (3,5-bis (trifluoromethyl) phenyl) ethoxy} methyl] -8-phenyl-1,7-diazaspiro [4.5] decan-2-one, and process |
ITMI20062449A1 (it) * | 2006-12-19 | 2008-06-20 | Dipharma Spa | Forma cristallina di rabeprazolo sodico |
WO2008081473A2 (en) * | 2006-12-29 | 2008-07-10 | Cadila Healthcare Limited | Process for preparing clopidogrel |
EP1970054A3 (en) | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel tablets |
EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
SG10201407538WA (en) * | 2009-08-14 | 2015-01-29 | Opko Health Inc | Intravenous formulations of neurokinin-1 antagonists |
WO2012123958A1 (en) | 2011-02-14 | 2012-09-20 | Cadila Healthcare Limited | Highly pure salts of clopidogrel free of genotoxic impurities |
US9233103B2 (en) | 2011-03-25 | 2016-01-12 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy |
TWI461215B (zh) * | 2011-06-24 | 2014-11-21 | Acenda Pharma Inc | 用以改善酯類前驅藥吸收率的方法與改良之藥學組合物 |
CA2844367C (en) * | 2011-06-24 | 2016-02-16 | Acenda Pharma, Inc. | Method and improved pharmaceutical composition for improving the absorption of an ester prodrug |
BR112015018144B1 (pt) * | 2013-02-06 | 2021-03-09 | Jingjun Huang | composição de emulsão água/óleo farmacêutica estável com gotículas de óleo manométricas, método para fazer a mesma e alta dose única de clopidogrel usada para tratar um paciente |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2652575B1 (fr) | 1989-09-29 | 1992-01-24 | Sanofi Sa | Procede de preparation d'acides alpha-bromo phenylacetiques. |
FR2664596B1 (fr) | 1990-07-10 | 1994-06-10 | Sanofi Sa | Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese. |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
HU225504B1 (en) | 1997-05-13 | 2007-01-29 | Sanofi Aventis | Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them |
HU222283B1 (hu) | 1997-05-13 | 2003-05-28 | Sanofi-Synthelabo | Eljárás tieno[3,2-c]piridin-származékok előállítására |
HU225503B1 (en) | 1997-05-13 | 2007-01-29 | Sanofi Aventis | Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them |
FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
HUP0200438A3 (en) * | 2002-02-06 | 2003-10-28 | Egis Gyogyszergyar Nyilvanosan | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them |
WO2005068471A1 (en) | 2004-01-13 | 2005-07-28 | Zentiva, A.S. | New crystalline forms of clopidogrel hydrobromide and methods of their preparation |
ZA200608569B (en) | 2004-04-20 | 2007-12-27 | Sanofi Aventis | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
-
2003
- 2003-09-11 GB GBGB0321256.0A patent/GB0321256D0/en not_active Ceased
-
2004
- 2004-09-09 CA CA2536052A patent/CA2536052C/en not_active Expired - Fee Related
- 2004-09-09 SI SI200432211T patent/SI1772456T1/sl unknown
- 2004-09-09 PT PT61248514T patent/PT1772456E/pt unknown
- 2004-09-09 EP EP04768414A patent/EP1618113B1/en not_active Expired - Lifetime
- 2004-09-09 HU HUE06124847A patent/HUE029256T2/en unknown
- 2004-09-09 CA CA2810312A patent/CA2810312A1/en not_active Abandoned
- 2004-09-09 AT AT04768414T patent/ATE487725T1/de active
- 2004-09-09 ES ES04768414T patent/ES2355729T3/es not_active Expired - Lifetime
- 2004-09-09 PL PL06124847T patent/PL1837337T3/pl unknown
- 2004-09-09 PL PL06124851T patent/PL1772456T3/pl unknown
- 2004-09-09 EP EP06124847.2A patent/EP1837337B1/en not_active Expired - Lifetime
- 2004-09-09 EP EP06124851.4A patent/EP1772456B1/en not_active Expired - Lifetime
- 2004-09-09 DK DK06124851.4T patent/DK1772456T3/en active
- 2004-09-09 ES ES06124851.4T patent/ES2528198T3/es not_active Expired - Lifetime
- 2004-09-09 US US10/571,419 patent/US7897613B2/en not_active Expired - Fee Related
- 2004-09-09 DE DE602004029999T patent/DE602004029999D1/de not_active Expired - Lifetime
- 2004-09-09 AU AU2004272337A patent/AU2004272337B2/en not_active Ceased
- 2004-09-09 WO PCT/GB2004/003867 patent/WO2005026174A1/en active Application Filing
- 2004-09-09 DK DK04768414.7T patent/DK1618113T3/da active
- 2004-09-09 EP EP09159491A patent/EP2149578A1/en not_active Withdrawn
- 2004-09-09 CA CA2809750A patent/CA2809750A1/en not_active Abandoned
-
2015
- 2015-01-12 CY CY20151100024T patent/CY1115917T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
GB0321256D0 (en) | 2003-10-08 |
SI1772456T1 (sl) | 2015-03-31 |
US7897613B2 (en) | 2011-03-01 |
US20070281964A1 (en) | 2007-12-06 |
ATE487725T1 (de) | 2010-11-15 |
DE602004029999D1 (de) | 2010-12-23 |
DK1772456T3 (en) | 2015-01-19 |
EP1618113B1 (en) | 2010-11-10 |
EP1837337B1 (en) | 2016-04-06 |
AU2004272337A1 (en) | 2005-03-24 |
CA2810312A1 (en) | 2005-03-24 |
CA2536052A1 (en) | 2005-03-24 |
CY1115917T1 (el) | 2017-01-25 |
ES2355729T3 (es) | 2011-03-30 |
CA2809750A1 (en) | 2005-03-24 |
DK1618113T3 (da) | 2011-02-07 |
EP1618113A1 (en) | 2006-01-25 |
PT1772456E (pt) | 2015-02-06 |
EP1772456B1 (en) | 2014-10-29 |
ES2528198T3 (es) | 2015-02-05 |
WO2005026174A1 (en) | 2005-03-24 |
HUE029256T2 (en) | 2017-02-28 |
CA2536052C (en) | 2013-06-25 |
AU2004272337B2 (en) | 2008-02-14 |
EP2149578A1 (en) | 2010-02-03 |
EP1772456A1 (en) | 2007-04-11 |
PL1837337T3 (pl) | 2017-02-28 |
EP1837337A1 (en) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115917T1 (el) | Νεες κρυσταλλικες πολυμορφες κλοπιδογρελης | |
EA201001548A1 (ru) | КИСЛЫЙ СУЛЬФАТ 2-АЦЕТОКСИ-5-(α-ЦИКЛОПРОПИЛКАРБОНИЛ-2-ФТОРБЕНЗИЛ)-4,5,6,7-ТЕТРАГИДРОТИЕНО[3,2-c]ПИРИДИНА И ЕГО ПОЛУЧЕНИЕ | |
EP1689393A4 (en) | PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS | |
PL1784409T3 (pl) | Podstawione amidy kwasów tienopirolokarboksylowych, amidy kwasów pirolotiazolokarboksylowych i pokrewne analogi jako inhibitory kinazy kazeinowej I epsilon | |
WO2005051358A8 (en) | Composition and method for enhancing bioavailability | |
TW200745137A (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
HRP20050641A2 (en) | New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof | |
BG108868A (en) | Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds | |
DE60230327D1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
NO20021919D0 (no) | Fremgangsmåte til fremstilling av fettsyre-kalsiumsalter fra oljer med höyt glyceridinnhold | |
NO996320D0 (no) | Korrosjonsinhibitor sammenstillinger samt metode for fremstilling av disse | |
EP1651646A4 (en) | NEW PROCESS FOR THE PREPARATION OF (+) - (S) -CLOPIDOGREL BISULFATE OF FORM I | |
ATE501153T1 (de) | Kristallisation von festen formen von clopidogreladditionssalzen | |
BG109429A (en) | A METHOD FOR OBTAINING A CRYSTAL POLYMORPHIC FORMAN FOR INHIBITING TROMBOCYTE AGGREGATION | |
GB0229630D0 (en) | Process for the production of synthetic magnesium silicate compositions | |
DE602006007483D1 (pl) | ||
ATE401332T1 (de) | Neue polymorphe von olanzapin-hydrochlorid | |
TNSN06331A1 (en) | Polymorphic forms of methyl (+) - (s) -alpha- (2-chlorophenyl) -6, 7-dihydrothieno [3,2-c] pyridine-5 (4h) acetate hydrobromide, clopidrogel hydrobromide | |
EP1538897A4 (en) | METHOD FOR CHANGING THE FATTY SURFACE COMPOSITION OF MILK | |
WO2007032023A3 (en) | A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof | |
BG109428A (en) | METHOD FOR OBTAINING AMORPHIC FORM OF MEDICINES INHIBITION OF THERAPEUTIC AGGREGATION | |
NO20073165L (no) | Fremgangsmate for fremstillingen av N-demetylolanzapin | |
SG156645A1 (en) | Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallization of salt and an aromatic sulfonic acid | |
ATE499371T1 (de) | Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz | |
HUP0402558A3 (en) | Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives |